Neuronetics, Inc (STIM) Enterprise Value to EBITDA Ratio
The price evolution of Neuronetics, Inc. (STIM) reflects the dynamics of the EV/EBITDA multiple, which currently stands at 0.00. Business efficiency relies on the automated production of magnetic stimulators with optimal capacity utilization. Sales stability is ensured by the precise delivery of high-precision instruments to medical centers, while the company's strong position in psychiatry guarantees the creation of non-invasive depression therapy systems as an alternative to medication.
Comprehensive metric breakdowns and analytics for neurostar.com (STIM)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
STIM - Net Financial Result|Projected Future Earnings Neuronetics, Inc.|STIM - Price to Earnings Ratio|Forward P/E Multiple Neuronetics, Inc.|STIM - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics, Inc|STIM - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Neuronetics|STIM - Earnings per share for the trailing year|Quarterly EPS earnings growth neurostar.com|STIM - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Neuronetics, Inc.
Analysis of all company metrics:NeuroStar STIM
The automation of Neuronetics, Inc. (STIM) production capacities ensures stable operational efficiency in the creation of magnetic stimulation systems. The company's current EV/EBITDA multiple compares the total enterprise value, including debt, with earnings before interest, taxes, depreciation, and amortization. This chart's price action allows for the determination of the real value of assets, stripped of accounting adjustments. A decline in this metric confirms the company is undervalued relative to its production potential.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|ReWalk Robotics Ltd. (LFWD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation AMIX|IVF (INVO Fertility) - EV/EBITDA Multiple|Company Value to EBITDA Bone Biologics Corp. BBLG|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|EV/EBITDA Multiple Biolase Inc. (BIOL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics DYNT|Business Value to Operating Income Before Depreciation FNA|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
